A Phase III Randomized Study of Radiotherapy With or Without BUdR Plus Procarbazine, CCNU, and Vincristine (PCV) for the Treatment of Anaplastic Astrocytomas

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BudR for the treatment of anaplastic astrocytoma.

M Prados;W Seiferheld;H Sandler;J Buckner;T Phillips;C Schultz;R Urtasun;R Davis;P Gutin;H Greenburg Int J Radiat Oncol Biol Phys 51(3):207(#1062)

Is time to tumor progression (TTP) an appropriate endpoint for clinical trials in anaplastic astrocytomas (AA)? Analysis of Radiation Therapy Oncology Group (RTOG) study 9404

CB Scott;W Seiferheld;M Prados;M Mehta;HM Sandler;WJ Curran Proc of the American Society of Clinical Oncology 20:51a(#200)

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

MD Prados;C Scott;H Sandler;JC Buckner;T Phillips;C Schultz;R Urtasun;R Davis;P Gutin;TL Cascino;HS Greenberg;WJ Curran Jr Int J Radiat Oncol Biol Phys 45(5):109-1115

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy

MD Prados;C Scott;WJ Curran Jr;DF Nelson;S Leibel;S Kramer Journal of Clinical Oncology 17(11):3389-3395

Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma RTOG 9404 interim report

M Prados;C Scott;T Phillips;R Davis;H Sandler;J Buckner;W Curran;C Schultz;R Urtason Int J Radiat Oncol Biol Phys 39(2):138(#8)

Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma: RTOG 9404

M Prados;C Scott;T Phillips;R Davis;H Sandler;J Buckner;W Curran;C Schultz;R Urtasun Proc of the Society for Neuro-Oncology, booklet:112